0001231919-23-000076.txt : 20231228 0001231919-23-000076.hdr.sgml : 20231228 20231228122818 ACCESSION NUMBER: 0001231919-23-000076 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231228 DATE AS OF CHANGE: 20231228 EFFECTIVENESS DATE: 20231228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IN8BIO, INC. CENTRAL INDEX KEY: 0001740279 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 825462585 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-500954 FILM NUMBER: 231521138 BUSINESS ADDRESS: STREET 1: EMPIRE STATE BUILDING STREET 2: 350 5TH AVENUE, SUITE 5330 CITY: NEW YORK STATE: NY ZIP: 10118 BUSINESS PHONE: (646) 600-6438 MAIL ADDRESS: STREET 1: EMPIRE STATE BUILDING STREET 2: 350 5TH AVENUE, SUITE 5330 CITY: NEW YORK STATE: NY ZIP: 10118 FORMER COMPANY: FORMER CONFORMED NAME: Incysus Therapeutics, Inc. DATE OF NAME CHANGE: 20180510 D 1 primary_doc.xml X0708 D LIVE 0001740279 IN8BIO, INC. EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY NEW YORK 10118 (646) 600-6438 DELAWARE Incysus Therapeutics, Inc. Corporation true William Ho c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Executive Officer Director Patrick McCall c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Executive Officer Alan S. Roemer c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Director Peter Brandt c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Director Emily Fairbairn c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Director Jeremy R. Graff c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Director Luba Greenwood c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Director Travis Whitfill c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Director Corinne Epperly c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Director Lawrence Lamb c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Executive Officer Trishna Goswami c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Executive Officer Kate Rochlin c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Executive Officer Biotechnology Decline to Disclose 06b false 2023-12-13 false true true false 0 Cantor Fitzgerald & Co. 134 None None 110 EAST 59TH STREET, 4TH FLOOR NEW YORK NY NEW YORK 10022 CA CALIFORNIA CT CONNECTICUT FL FLORIDA IL ILLINOIS MD MARYLAND NJ NEW JERSEY NY NEW YORK SC SOUTH CAROLINA TX TEXAS false 14425013 14425013 0 This amount does not include potential proceeds to the issuer upon exercise of warrants. false 20 643470 0 0 false IN8BIO, INC. /s/ Patrick McCall Patrick McCall Chief Financial Officer 2023-12-28